hydroxychloroquine has been researched along with Fatty Liver in 1 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Fatty Liver: Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ferron, PJ | 1 |
| Le Daré, B | 1 |
| Bronsard, J | 1 |
| Steichen, C | 1 |
| Babina, E | 1 |
| Pelletier, R | 1 |
| Hauet, T | 1 |
| Morel, I | 1 |
| Tarte, K | 1 |
| Reizine, F | 1 |
| Clément, B | 1 |
| Fromenty, B | 1 |
| Gicquel, T | 1 |
1 other study available for hydroxychloroquine and Fatty Liver
| Article | Year |
|---|---|
Molecular Networking for Drug Toxicities Studies: The Case of Hydroxychloroquine in COVID-19 Patients.
Topics: Aged; Antiviral Agents; Cell Line; Cell Survival; Chemical and Drug Induced Liver Injury; Correlatio | 2021 |